{"changes":[],"country":"US","description":"Atavistik Bio develops precision allosteric small molecule therapeutics by identifying hidden binding pockets on drug targets. The company focuses on patients with oncology and rare disease needs where treatment options are limited. Its proprietary AMPS platform combines computational and experimental techniques to unlock cryptic allosteric sites.","domain":"atavistik.bio","employees":null,"founded":2020,"fundingTotalQuarantined":false,"githubOrg":"atavistikbio","githubStars":null,"industry":"bio","investors":[],"lat":42.365635,"lng":-71.104002,"location":"Cambridge USA","name":"Atavistik Bio","rounds":[{"amountQuarantined":false,"amountUsd":120000000,"currency":"USD","date":"2025-12-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-17","status":"attributed","url":null},"status":"attributed","type":"series-d+","url":null}],"slug":"atavistik-bio","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-17","status":"attributed","url":null},{"fact":"existence","publisher":"atavistik.bio","retrievedAt":"2026-05-17","status":"self-reported","url":"https://atavistik.bio"},{"fact":"description","publisher":"atavistik.bio","retrievedAt":"2026-05-17","status":"self-reported","url":"https://atavistik.bio"}],"stage":"series-b+","techStack":[],"totalRaisedUsd":120000000,"updatedAt":"2026-05-17"}